Cookies hos Endavu

Vi vil gerne bruge cookies til statistik og annoncer, også fra vores partnere. Du kan altid ændre dit valg.

·Læs om cookies
  • Platform

  • Aktiesparekonto

  • Priser

  • Blog

  • MCP

  • Support

  • Populære aktier

InstagramLinkedInTikTokFacebook
Opret konto
Få appenScan koden
QR-kode til download af Endavu-appen
Log ind
PR80

BLS Pharmaceuticals

Xetra

Køb BLS Pharmaceuticals hos Endavu

  1. 1Opret en konto. Det er gratis og tager få minutter.
  2. 2Indsæt penge og vælg din investering.
  3. 3Køb BLS Pharmaceuticals.
  • Lav kurtage
  • Kan ligge på aktiesparekonto

BLS Pharmaceuticals · PR80

Fra 1 stk.

60.000 brugere er allerede i gang

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BLS PHARMACEUTICALS MED ENDAVU: Køb BLS Pharmaceuticals ($PR80) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i BLS Pharmaceuticals, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

BLS Pharmaceuticals Limited is an Australian pharmaceutical and life sciences company headquartered in Sydney. The company focuses on the manufacture, development, and commercialisation of regulated therapeutic products and active pharmaceutical ingredients across the healthcare sector. Through its wholly owned subsidiary Breathe Life Sciences, BLS Pharmaceuticals operates GMP-licensed facilities that handle medicinal cannabis, psychedelic medicines such as MDMA and psilocybin, and other controlled pharmaceutical products. The group provides pharmaceutical manufacturing, wholesale, distribution, import, export, and contract drug manufacturing services, serving licensed clinics, pharmacies, wholesale distributors, cultivators, active ingredient manufacturers, and pharmaceutical brand sponsors in Australia, Europe, Japan, the United States, and the United Kingdom. In addition to third-party manufacturing, BLS Pharmaceuticals markets own-brand prescription medicines and consumer health products, including cannabinoids, probiotics, novel foods, and wellness supplements, under brands such as Dr Watson and PCC. Founded in 1998 and based in Sydney, Australia, the company plays a specialised role in the regulated therapeutics and consumer health markets.

Information

TickerPR80
Land
Australien
Hjemmesideblspharma.com
SektorSundhed
IndustriBioteknologi